Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
search
Subscribe
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
Subscribe
FREE
19 Oct 2025
Enhancing PPIE in Allergy Research and Practice
Enhancing PPIE in allergic disease research offers tangible benefits, from improving patient outcomes to ensuring studies align with real-world needs.
18 Oct 2025
NOD1 Signalling in Acute Liver Failure
The study examined transcriptome data from patients with HBV-induced acute liver failure and healthy controls, identifying key genes and pathways linked to disease progression.
18 Oct 2025
ESMO 2025: DESTINY-Breast11 Trial Results Revealed
The DESTINY-Breast11 phase 3 trial presented at ESMO 2025 revealed that the anthracycline-free neoadjuvant T-DXd-THP regimen achieved a 67.3% pathologic complete response rate.
18 Oct 2025
Mother’s Voice Enhances Development in Premature Babies
A new trial shows that hearing their mother’s voice helps premature babies build neural connections essential for language.
18 Oct 2025
EACS 2025: Doxy-PEP Cuts Chlamydia and Syphilis Risk in Men Living With HIV
EACS 2025 study shows doxycycline prophylaxis reduced chlamydia and syphilis rates in Swiss men with HIV, with no effect against gonorrhoea.
18 Oct 2025
Barriers to Timely Melanoma Diagnosis in Latino Patients
Many participants reported that a lack of understanding about skin cancer symptoms led to delays in seeking medical help.
17 Oct 2025
Changes in Cardiac Troponin I Levels in Transgender Adults
A first-of-its-kind trial reveals how hormone therapy affects Cardiac Troponin I levels in transgender adults.
17 Oct 2025
Improving Treatment Intensification in mCSPC
The IMPLEMENT study explored why first-line treatment intensification remains underutilised and how clinicians’ behaviours, beliefs, and environments influence its uptake.
ViiV's bi-monthly HIV injection approved by NICE
Injectable HIV PrEP marks a breakthrough in prevention, providing a new option for patients in England unable to take daily pills.
17 Oct 2025
EACS 2025: Over Half of HIV Diagnoses in Migrants Occur Years Post-Migration
EACS 2025 data show over half of HIV diagnoses among migrants in Switzerland occur post-migration, highlighting need for targeted testing and prevention.
←
1
2
3
4
5
…
1,261
1,262
1,263
→
We’ve noticed you’re accessing
from
North/South America.
View
View